These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37484708)

  • 1. Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
    J Transl Autoimmun; 2023 Dec; 7():100206. PubMed ID: 37484708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
    J Autoimmun; 2023 Apr; 136():103029. PubMed ID: 36996698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
    J Transl Autoimmun; 2023 Dec; 7():100209. PubMed ID: 37520890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy.
    Kockx M; Roberts L; Wang J; Tran C; Brown MA; Kritharides L
    Atheroscler Plus; 2022 Apr; 48():12-19. PubMed ID: 36644562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.
    Nicholls SJ; Ruotolo G; Brewer HB; Kane JP; Wang MD; Krueger KA; Adelman SJ; Nissen SE; Rader DJ
    J Am Coll Cardiol; 2015 Nov; 66(20):2201-2210. PubMed ID: 26564598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis.
    Karpouzas GA; Ormseth SR; Hernandez E; Budoff MJ
    Rheumatology (Oxford); 2022 May; 61(5):1857-1866. PubMed ID: 34373923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events.
    Magnoni M; Andreini D; Pirillo A; Uboldi P; Latini R; Catapano AL; Maggioni AP; Norata GD;
    Ann Med; 2022 Dec; 54(1):1036-1046. PubMed ID: 35438019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
    He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
    Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity.
    van Velzen DM; Adorni MP; Zimetti F; Strazzella A; Simsek S; Sirtori CR; Heijer MD; Ruscica M
    Atherosclerosis; 2021 Apr; 323():44-53. PubMed ID: 33836456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
    Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
    Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis.
    Karpouzas GA; Papotti B; Ormseth S; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff M; Ronda N
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36113961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
    Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
    Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
    Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
    Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion.
    Santovito D; Marcantonio P; Mastroiacovo D; Natarelli L; Mandolini C; De Nardis V; Paganelli C; De Cesare D; Affaitati G; Giamberardino MA; Stellin L; Pinelli M; Weber C; De Blasis G; Occhiuzzi U; Bucci M; Desideri G; Cipollone F
    Int J Cardiol; 2020 Jan; 299():249-253. PubMed ID: 31409515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
    He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
    Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Lipoprotein(a) Levels Lower ABCA1 Cholesterol Efflux Capacity.
    Tavori H; Fenton AM; Plubell DL; Rosario S; Yerkes E; Gasik R; Miles J; Bergstrom P; Minnier J; Fazio S; Pamir N
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4793-4803. PubMed ID: 31220285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.